Preclinical Study of the Pikamilon Injection Drug

[Article in Russian]

NPO "Vitamins", Nauchny proezd, 
14 A, Moscow 117246, USSR

Abstract

Pikamilon is an original vasoactive and nootropic drug used in medicine as 0,01 g, 0,02 g, 0,05 g tablets.  The new pikamilon drug form has been developed.  It represents 5% and 10% solutions for injections in ampules.  In experiments on animals the new drug form has been found to possess pronounced cerebrovascular activity and antihypoxic effect as the before studied substance of pikamilon.  Pikamilon posesses low toxicity by singular and long administrations, it doesn't produce any local irritative effects by intramuscular and subcutaneous administrations.  Pikamilon has not any negative effect on animal blood vessels. The drug is not an allergen.  Pikamilon doesn't possess any cancerogenic activity.

cataract | Galantamine | Vinpocetine | Idebenone | Pyritinol | Modafinil
Deprenyl | Piracetam
| CDP Choline  Memantine | stroke | benfotiamine

 

 

Hit Counter